Trade Karuna Therapeutics, Inc. - KRTX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.41 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 329.51 |
| Open | 329.63 |
| 1-Year Change | 75.95% |
| Day's Range | 329.56 - 329.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 15, 2024 | 329.60 | 0.03 | 0.01% | 329.57 | 329.76 | 329.54 |
| Mar 14, 2024 | 329.51 | -0.05 | -0.02% | 329.56 | 329.59 | 329.41 |
| Mar 13, 2024 | 321.75 | -0.98 | -0.30% | 322.73 | 322.81 | 320.58 |
| Mar 12, 2024 | 322.12 | 2.81 | 0.88% | 319.31 | 322.12 | 319.11 |
| Mar 11, 2024 | 319.00 | 0.24 | 0.08% | 318.76 | 319.81 | 318.06 |
| Mar 8, 2024 | 319.49 | 2.23 | 0.70% | 317.26 | 319.55 | 317.26 |
| Mar 7, 2024 | 317.25 | -0.56 | -0.18% | 317.81 | 319.31 | 316.59 |
| Mar 6, 2024 | 318.22 | 0.22 | 0.07% | 318.00 | 319.55 | 316.48 |
| Mar 5, 2024 | 318.43 | 0.67 | 0.21% | 317.76 | 319.05 | 317.18 |
| Mar 4, 2024 | 317.86 | 3.05 | 0.97% | 314.81 | 318.02 | 314.81 |
| Mar 1, 2024 | 315.98 | 2.20 | 0.70% | 313.78 | 316.75 | 313.78 |
| Feb 29, 2024 | 313.69 | -1.12 | -0.36% | 314.81 | 315.91 | 313.69 |
| Feb 28, 2024 | 315.34 | 1.03 | 0.33% | 314.31 | 316.55 | 314.31 |
| Feb 27, 2024 | 314.65 | -0.11 | -0.03% | 314.76 | 317.83 | 313.88 |
| Feb 26, 2024 | 315.69 | -3.62 | -1.13% | 319.31 | 319.83 | 295.80 |
| Feb 23, 2024 | 320.06 | 2.83 | 0.89% | 317.23 | 320.19 | 317.23 |
| Feb 22, 2024 | 319.06 | 1.00 | 0.31% | 318.06 | 319.26 | 318.06 |
| Feb 21, 2024 | 318.70 | 1.29 | 0.41% | 317.41 | 318.72 | 317.41 |
| Feb 20, 2024 | 318.20 | 0.89 | 0.28% | 317.31 | 318.80 | 317.31 |
| Feb 16, 2024 | 318.06 | -0.70 | -0.22% | 318.76 | 319.60 | 317.22 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Karuna Therapeutics, Inc. Company profile
About Karuna Therapeutics Inc
Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is for the treatment of psychosis in Alzheimer's disease (AD), which is the prevalent subtype of dementia-related psychosis (DRP). KarXT is a combination of xanomeline and trospium. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms associated with schizophrenia and dementia-related psychosis (DRP). Its muscarinic receptors serve a number of physiological roles, including in cognitive, behavioral, sensory, motor and autonomic processes.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Karuna Therapeutics Inc revenues increased from $0K to $37M. Net loss increased from $68.6M to $143.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $32.3M to $98.7M (expense), General and administrative - Other increase from $6.5M to $25.2M (expense).
| Industry: | Bio Therapeutic Drugs |
99 High Street
26th Floor
BOSTON
MASSACHUSETTS 02110
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com